← Leaderboards
Mirko Paiardini
University Of Pennsylvania
$32,628,549
Attributed
$60,491,028
Total exposure
20
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.9M · FY2009–25$10M$7.5M$5M$2.5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$60,491,028 · 20
By mechanism
R01$26,053,403 · 8
UM1$25,334,968 · 1
R33$3,040,447 · 2
R56$2,478,089 · 3
P01$2,449,708 · 2
R21$985,825 · 2
Top collaborators
- Guido Silvestri7 shared
- Michael Marcel Lederman6 shared
- Jacob D Estes5 shared
- Deanna A Kulpa5 shared
- Sanjay B. Maggirwar5 shared
- Vincent Charles Marconi5 shared
- Siddappa N Byrareddy4 shared
- Katharine June Bar3 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- George M Shaw$56,045,759
- Katharine June Bar$15,418,177
- Michael R Betts$25,350,826
- Irwin M Chaiken$15,499,914
- Dennis Larry Kolson$16,900,832
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionMacaca MulattaCellsIn VivoVirus ReplicationHiv InfectionsVirusViralInterruptionAnimalsBaseImmuneAntiretroviral TherapyViral ReservoirBloodCd4 Positive T LymphocytesViral ReboundResponseAcquired Immunodeficiency SyndromeMaintenanceMediatingNonhuman PrimateInsightInflammation
Grant awards (59)
Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV)$4,663,729
UM1 · FY2025 · AI · contact PI
Determining the effects of broadly neutralizing antibodies at antiretroviral therapy initiation$840,170
R01 · FY2025 · AI
Generation of highly differentiated NK cells to synergize with broadly neutralizing antibodies to establish viral control in absence of ART$769,220
R01 · FY2025 · AI · contact PI
Revealing the role of platelets in promoting HIV reservoir seeding and persistence in the CNS-resident myeloid cells$630,295
R01 · FY2025 · NS
Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV)$4,667,081
UM1 · FY2024 · AI · contact PI
Determining the effects of broadly neutralizing antibodies at antiretroviral therapy initiation$825,084
R01 · FY2024 · AI
Generation of highly differentiated NK cells to synergize with broadly neutralizing antibodies to establish viral control in absence of ART$799,017
R01 · FY2024 · AI · contact PI
Determining the relative contribution of CD4 T cells and macrophages to HIV persistence and rebound$765,954
R01 · FY2024 · MH · contact PI
Revealing the role of platelets in promoting HIV reservoir seeding and persistence in the CNS-resident myeloid cells$516,381
R01 · FY2024 · NS
Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV)$5,636,888
UM1 · FY2023 · AI · contact PI
Determining the effects of broadly neutralizing antibodies at antiretroviral therapy initiation$880,331
R01 · FY2023 · AI
Revealing the role of platelets in promoting HIV reservoir seeding and persistence in the CNS-resident myeloid cells$818,512
R01 · FY2023 · NS
Generation of highly differentiated NK cells to act in synergy with broadly neutralizing antibodies to reduce the SIV reservoir and establish viral control in absence of ART$812,810
R56 · FY2023 · AI · contact PI
Determining the relative contribution of CD4 T cells and macrophages to HIV persistence and rebound$783,067
R01 · FY2023 · MH · contact PI
Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV)$5,412,341
UM1 · FY2022 · AI · contact PI
Revealing the role of platelets in promoting HIV reservoir seeding and persistence in the CNS-resident myeloid cells$818,514
R01 · FY2022 · NS
Determining the relative contribution of CD4 T cells and macrophages to HIV persistence and rebound$786,706
R01 · FY2022 · MH · contact PI
Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV)$4,954,929
UM1 · FY2021 · AI · contact PI
Revealing the role of platelets in promoting HIV reservoir seeding and persistence in the CNS-resident myeloid cells$833,889
R01 · FY2021 · NS
Determining the relative contribution of CD4 T cells and macrophages to HIV persistence and rebound$785,703
R01 · FY2021 · MH · contact PI
Core B - Nonhuman Primates - Emory University$327,665
P01 · FY2021 · AI · contact PI
Mobilizing host defenses to lymphoid sites of HIV persistence to induce remission$897,741
R56 · FY2020 · AI · contact PI
Limiting HIV establishment and maintenace by preserving intestinal immunity$828,836
R01 · FY2020 · AI
Determining the relative contribution of CD4 T cells and macrophages to HIV persistence and rebound$805,328
R01 · FY2020 · MH · contact PI
Core B - Nonhuman Primates - Emory University$682,455
P01 · FY2020 · AI · contact PI
Limiting HIV establishment and maintenace by preserving intestinal immunity$829,776
R01 · FY2019 · AI
Immune based interventions for HIV eradication$783,714
R01 · FY2019 · AI · contact PI
Core B - Nonhuman Primates - Emory University$683,344
P01 · FY2019 · AI · contact PI
Limiting HIV establishment and maintenace by preserving intestinal immunity$829,440
R01 · FY2018 · AI
Immune based interventions for HIV eradication$828,064
R01 · FY2018 · AI · contact PI
Targeting Cytolytic Cells to Lymphoid Sites of HIV Persistence.$480,497
R33 · FY2018 · AI
Core B - Nonhuman Primates - Emory University$69,529
P01 · FY2018 · AI · contact PI
Immune based interventions for HIV eradication$861,125
R01 · FY2017 · AI · contact PI
Central memory CD4 T cell infection: key role in ART response and HIV persistence$853,991
R01 · FY2017 · AI · contact PI
Limiting HIV establishment and maintenace by preserving intestinal immunity$847,715
R01 · FY2017 · AI
Core B - Nonhuman Primates - Emory University$686,715
P01 · FY2017 · AI · contact PI
Persistent Virus Reservoirs in SIV-infected Macaques$521,698
R33 · FY2017 · AI · contact PI
Targeting Cytolytic Cells to Lymphoid Sites of HIV Persistence.$490,442
R33 · FY2017 · AI
Immune based interventions for HIV eradication$877,752
R01 · FY2016 · AI · contact PI
Central memory CD4 T cell infection: key role in ART response and HIV persistence$869,119
R01 · FY2016 · AI · contact PI
Persistent Virus Reservoirs in SIV-infected Macaques$521,665
R33 · FY2016 · AI · contact PI
Targeting Cytolytic Cells to Lymphoid Sites of HIV Persistence.$492,372
R33 · FY2016 · AI
Immune based interventions for HIV eradication$890,819
R01 · FY2015 · AI · contact PI
Central memory CD4 T cell infection: key role in ART response and HIV persistence$881,672
R01 · FY2015 · AI · contact PI
Persistent Virus Reservoirs in SIV-infected Macaques$533,773
R33 · FY2015 · AI · contact PI
Targeting Cytolytic Cells to Lymphoid Sites of HIV Persistence.$262,086
R21 · FY2015 · AI
Central memory CD4 T cell infection: key role in ART response and HIV persistence$895,012
R01 · FY2014 · AI · contact PI
Targeting Cytolytic Cells to Lymphoid Sites of HIV Persistence.$234,742
R21 · FY2014 · AI
Persistent Virus Reservoirs in SIV-infected Macaques$221,247
R21 · FY2014 · AI · contact PI
Central memory CD4 T cell infection: key role in ART response and HIV persistence$873,611
R01 · FY2013 · AI · contact PI
TH17 cells in AIDS pathogenesis and HIV vaccines$326,311
R01 · FY2013 · AI · contact PI
Persistent Virus Reservoirs in SIV-infected Macaques$267,750
R21 · FY2013 · AI · contact PI
TH17 cells in AIDS pathogenesis and HIV vaccines$554,946
R01 · FY2012 · AI · contact PI
TH17 cells in AIDS pathogenesis and HIV vaccines$566,389
R01 · FY2011 · AI · contact PI
TH17 CELLS IN AIDS PATHOGENESIS AND HIV VACCINES$74,294
P51 · FY2011 · RR · contact PI
HOMEOSTASIS OF CD4+ T CELLS IN NONHUMAN PRIMATES$74,294
P51 · FY2011 · RR · contact PI
Homeostasis of CD4+ T cells in non-human primates$767,538
R56 · FY2010 · AI · contact PI
TH17 cells in AIDS pathogenesis and HIV vaccines$445,687
R01 · FY2010 · AI · contact PI
TH17 cells in AIDS pathogenesis and HIV vaccines$551,253
R01 · FY2009 · AI · contact PI